Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Wei Lin Tung"'
Autor:
Kao-Chi Chang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Yung-Yu Hsieh, Wei-Ming Chen, Yi-Hsing Chen, Chun-Hsien Chen, Chi-Wei Yen, Huang-Wei Xu, Wei-Lin Tung, Chao-Hung Hung, Sheng-Nan Lu, Te-Sheng Chang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Clinical trials showed pangenotypic direct-acting antivirals’ (DAAs) excellent efficacy and safety when treating hepatitis C virus (HCV). Two pangenotypic regimens were examined, glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/velpatasvi
Externí odkaz:
https://doaj.org/article/c3f883780e4f498eae4652d3f293f1fe
Autor:
Yung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, Yung-Yu Hsieh, Shui-Yi Tung, Yi-Hsing Chen, Chih-Wei Yen, Wei-Lin Tung, Kao-Chi Chang, Wei-Ming Chen, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272567 (2022)
Real-world data on the effectiveness of glecaprevir/pibrentasvir (GLE/PIB) for patients with HCV infection and compensated cirrhosis is limited, especially for the 8-week regimen and in an Asian population. This retrospective study enrolled 159 conse
Externí odkaz:
https://doaj.org/article/fc0f2f09b71f471dacc0d8df40376f44
Autor:
Huang-Wei Xu, Chi-Wei Yen, Chen-Heng Shen, Kao-Chi Chang, Wei-Lin Tung, Kuo-Liang Wei, Te-Sheng Chang, Yi-Hsing Chen, Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Sheng-Nan Lu, Chao-Hung Hung, Shui-Yi Tung
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Background/Purpose of StudyClinical trials have demonstrated excellent efficacy and safety of pangenotypic direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV). However, there are limited large-scale real-world data on these p
Autor:
Hsu Feng Lu, Ching Sung Lee, Wei Lin Tung, Yung Liang Chen, Fang Ming Huang, Wen Yen Liao, Yi Ping Huang, Jai Sing Yang, Jing Gung Chung
Publikováno v:
Journal of Agricultural and Food Chemistry. 60:7634-7643
Indole-3-carbinol (I3C), a potential anticancer substance, can be found in cruciferous (cabbage family) vegetables, mainly cauliflower and Chinese cabbage. However, the bioactivity of I3C on the apoptotic effects of murine leukemia WEHI-3 cells and p
Publikováno v:
Microporous and Mesoporous Materials. 152:58-63
Ultrathin mesoporous TiO 2 coatings with a wormhole-like architecture were synthesized using evaporation-induced self-assembly method. The morphological and chemical structures of TiO 2 films were characterized using small-angle and large-angle X-ray
Publikováno v:
The Prostate. 71:675-681
BACKGROUND. Prostatic small cell carcinoma (SCC) is a rare variant of prostate cancer. It is extremely aggressive and resistant to available therapies with a median survival range of 5–17 months. No standard chemotherapeutic regimen has been establ
Publikováno v:
Advanced Functional Materials. 19:3396-3403
The multifunctional nanodevice described here integrates nanoscaled imaging, targeting, and controlled drug delivery, as well as the capability to monitor, in situ, the amount of drug released from the nanodevice with single-cell resolution. The nano
Publikováno v:
Advanced Functional Materials. 18:2946-2955
Surfactant-free, self-assembled iron oxide/silica core-shell (SAIO@SiO 2 ) nanocarriers were synthesized as bifunctional magnetic vectors that can be triggered for the controlled release of therapeutic agents by an external magnetic field. In additio
Autor:
Yen-Yu Liu, Li-Ying Huang, Ming-Chien Yang, Kun-Ho Liu, Ting-Yu Liu, Wei-Lin Tung, Chih-Shin Chao
Publikováno v:
Journal of nanoscience and nanotechnology. 12(6)
Novel amphipathic derivative of chitosan (carboxymethyl-hexanoyl chitosan, CHC) was made into mats of nanofibers (approximately 100 nm) via electrospinning. The resulting mats were further cross-linked with genipin. The morphology of CHC nanofibers w
Publikováno v:
The Prostate. 71(7)
Prostatic small cell carcinoma (SCC) is a rare variant of prostate cancer. It is extremely aggressive and resistant to available therapies with a median survival range of 5-17 months. No standard chemotherapeutic regimen has been established for its